Effects of a dawn-dusk simulation on circadian rest-activity cycles, sleep, mood and well-being in dementia patients.


Journal

Experimental gerontology
ISSN: 1873-6815
Titre abrégé: Exp Gerontol
Pays: England
ID NLM: 0047061

Informations de publication

Date de publication:
09 2019
Historique:
received: 28 03 2019
revised: 02 06 2019
accepted: 24 06 2019
pubmed: 30 6 2019
medline: 12 9 2020
entrez: 29 6 2019
Statut: ppublish

Résumé

Light is the most powerful "zeitgeber" signal to synchronize circadian sleep-wake cycles. In dementia, these rhythms are often fragmented - probably due to loss of neuronal function of the suprachiasmatic nuclei (the biological "master clock" in the brain) and/or weakness of external zeitgebers. We investigated the effects of a prototype dawn-dusk simulator (DDS) on circadian rest-activity cycles, sleep, mood and well-being in a balanced crossover design during fall and winter in 20 institutionalized patients with dementia (86 ± 6 y, 17 f). All participants had one baseline week followed by exposure to individually timed DDS over their beds for 7-8 weeks. They spent 8 weeks without DDS as a control. Mood, self-reliant daily activity, social behavior, agitation, and quality of life were assessed by standardized questionnaires and visual analogue scales, regularly rated by trained caregivers. Circadian and sleep characteristics of their rest-activity cycles were analyzed by actimetry over 17 weeks. DDS exposure led to significantly better mood in the morning hours after waking. The effects were most pronounced in the second 4 weeks with DDS, indicating that positive effects emerged gradually. Differences in circadian rest-activity cycles and sleep were mainly age-dependent. We found statistically significant correlations between measures of higher quality of life and better mood, greater alertness and circadian rhythm stability. We conclude that continuous, long-term application of dawn-dusk simulation at the sleep-wake transitions appears to increase external zeitgeber strength in institutionalized patients with dementia. The DDS may provide an effective, non-invasive tool to improve mood and ameliorate patients' quality of life.

Identifiants

pubmed: 31252161
pii: S0531-5565(19)30234-7
doi: 10.1016/j.exger.2019.110641
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

110641

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Vivien Bromundt (V)

Sleep-Wake-Epilepsy-Center, Dept. of Neurology, Inselspital, Bern University Hospital, Bern, Switzerland.

Anna Wirz-Justice (A)

Centre for Chronobiology, Transfaculty Research Platform Molecular and Cognitive Neurosciences, Psychiatric Hospital of the University of Basel, Basel, Switzerland.

Marc Boutellier (M)

Nursing Home Hofmatt, Münchenstein, BL, Switzerland.

Seraina Winter (S)

Nursing Home Hofmatt, Münchenstein, BL, Switzerland.

Markus Haberstroh (M)

Haberstroh Architects, Basel, Switzerland.

Michael Terman (M)

Columbia University, New York, USA.

Mirjam Münch (M)

Charité, University Medicine Berlin, Institute of Physiology and Institute of Medical Immunology, Berlin, Germany. Electronic address: m.munch@massey.ac.nz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH